| Primary information |
|---|
| ID | antitb_1649 |
| Peptide Name | Tuftsin peptide conjugate compound |
| Sequence | SEFAYGSFVRTVSLPV |
| N-terminal Modification | INH is conjugated |
| C-terminal Modification | Free |
| Chemical Modification | None |
| Linear/ Cyclic | Cyclic |
| Length | 16 |
| Chirality | L |
| Nature | Cationic |
| Source | Natural |
| Origin | Derived from 16-kDa protein of M. tuberculosis and tuftsin-derived peptides |
| Species | Mycobacterium Tuberculosis |
| Strain | Mycobacterium tuberculosis H37Rv ATCC 27294 |
| Inhibition Concentartion | MIC = 2.54 μg/ml |
| In vitro/In vivo | in vitro |
| Cell Line | NA |
| Inhibition Concentartion | NA |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | Cell wall biosynthesis inhibition |
| Target | NA |
| Combination Therapy | Peptide + INH(0.24 ug/ml) |
| Other Activities | NA |
| Pubmed ID | 19319854 |
| Year of Publication | 2009 |
| 3-D Structure | NA |